Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,212 | 0.0% | 64,637 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,665 | 0.0% | 34,838 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 3,001 | 0.0% | 95,214 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 2,954 | 0.0% | 90,195 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,390 | 0.0% | 38,454 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 2,955 | 0.0% | 94,761 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 2,701 | 0.0% | 100,961 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 3,249 | 0.0% | 95,255 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 2,292 | 0.0% | 79,205 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,214 | 0.0% | 44,042 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 1,503 | 0.0% | 49,993 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 1,750 | 0.0% | 48,311 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 1,914 | 0.0% | 53,671 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 1,833 | 0.0% | 54,151 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,669 | 0.0% | 57,696 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 2,249 | 0.0% | 69,600 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 2,030 | 0.0% | 69,600 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,856 | 0.0% | 69,600 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 2,143 | 0.0% | 69,600 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 1,822 | 0.0% | 69,600 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 1,751 | 0.0% | 69,600 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 1,632 | 0.0% | 78,300 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 1,862 | 0.0% | 78,400 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 1,477 | 0.0% | 82,100 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,753 | 0.0% | 73,900 | 12/31/2019 |